Julie Delaloye

Senior Research Associate


Julie Delaloye obtained her medicine diploma as well as her thesis at the Biology and Medicine Facutly (FBM) at Lausanne University in 2004. She then continued her clinical formation at Centre Hospitalier Universitaire Vaudois (CHUV) and at the Hôpital de Sion with a specialisation in internal medecine, infectiology and intensive care.


Next to her clinical activity, she is involved in many projects in research in infectiology diseases notably in relation to intensive care. She holds also a CAS in clinical research at the Lausanne University in 2009, followed by a MAS in the area « Drug discovery and clinical development » at the Geneva University from 2017.  Julie Delaloye works a medical doctor in the Intensive Care Service in Hôpital in Sion.

In addition to her activity as medical doctor, Julie Delaloye is poet. She was awarded the Prix de la Vocation de la Fondation Bleustein-Blanchet in Paris in 2008, with her first book « Dans un ciel de février » published in Editions Cheyne in 2008. A second poetry book is published in 2015 « Malgré la neige » Editions Cheyne (selected for the final of the selection Prix Apollinaire 2016).

Because of her double vocation as medical doctor and poet, Julie Delaloye undertakes a thinking process on the place of the poetry in the medicine and the medical history of the patients. Since 2016, Julie Delaloye organises « Le Printemps de la poésie » in the hospitals of French part of the Switzerland, with the intention to give access to poetry to patients. Distributions of poems, expositions, reading and poetry meetings are also organised each year in the hospitals in Romandie.



  • poésie et médecine, fractures et interactions, pouvoir thérapeutique de la parole poétique à l’ère de la médecine moderne
  • Développement d’outils diagnostics et thérapeutiques dans la prise en charge du sepsis et du choc septique aux soins intensifs



Mandatory lesson of Medical Humanities, unité Neurosciences (BA3)




  • Ce qu’il reste de joie, Collection « Tirage limité », Editions de la Sirène, 2019
  • Malgré la neige, Cheyne, 2015
  • Dans un ciel de février, Cheyne, 2008



  • Hommage à Yves Bonnefoy, Les Carnets d’Eucharis, 2020
  • Hommage à Gustave Roud, Les Carnets d’Eucharis, 2018
  • Une rencontre, Hommage à Anne Perrier, La Revue des Belles-Lettres, 2018
  • Poèmes, La Traverse du tigre, hors-série Poésie suisse romande, Les carnets d’Eucharis, 2017 



  • « Printemps de la poésie à l’hôpital », HUG, CHUV, Hôpital du Valais (from 2016)
  • Camus et la poésie, La Saline royale d'Arc-et-Senans, France, 2018 (organised by Danièle Leclair, Université Paris Descartes and UMR 7172 Thalim-CNRS/ Sorbonne nouvelle and Alexis Lager (Société des études camusiennes),
  • Poésie et peinture, Les liens indicibles, Fondation Gianadda, 2018
  • Dimensions thérapeutiques de la parole dans l'Antiquité: des représentations poétiques aux réactions émotionnelles (organisé par Vasiliki Kondylaki, David Bouvier, Vincent Barras), Université de Lausanne, 2018
  • La figure du poète-médecin, XXe-XXIe siècles, Université de Fribourg, 2017 (organised by Alexandre Wenger, Université Fribourg/Genève)



  • Künzler-Heule P, Engberg S, Battegay M, Schmidt AJ, Fierz K, Nguyen H, Kocher A, Nöstlinger C, Hampel B, Stöckle M, Béguelin C, Delaloye J, Schmid P, Flepp M, Rougement M, Braun DL, Fehr J, Nicca D; Swiss HIV Cohort Study (SHCS). Screening HIV-positive men who have sex with men for hepatitis C re-infection risk: is a single question on condom-use enough? A sensitivity analysis. BMC Infect Dis. 2019 Sep 18;19(1):821.
  • Braun DL, Hampel B, Martin E, Kouyos R, Kusejko K, Grube C, Flepp M, Stöckle M, Conen A, Béguelin C, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study . High Number of Potential Transmitters Revealed in a Population-based Systematic Hepatitis C Virus RNA Screening Among Human Immunodeficiency Virus-infected Men Who Have Sex With Men. Clin Infect Dis. 2019 Feb 1;68
  • Braun DL, Hampel B, Kouyos R, Nguyen H, Shah C, Flepp M, Stöckle M, Conen A, Béguelin C, Künzler-Heule P, Nicca D, Schmid P, Delaloye J, Rougemont M, Bernasconi E, Rauch A, Günthard HF, Böni J, Fehr JS; Swiss HIV Cohort Study . High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus-coinfected Men Who Have Sex With Men.
  • Fernández-Ruiz M, Meije Y, Manuel O, Akan H, Carratalà J, Aguado JM, Delaloye J.ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Introduction). Clin Microbiol Infect. 2018 Jun;24 Suppl 2:S2-S9.
  • Delaloye J, Pillonel T, Smaoui M, Znazen A, Abid L, Greub G. Culture-independent genome sequencing of Coxiella burnetii from a native heart valve of a Tunisian patient with severe infective endocarditis. New Microbes New Infect. 2017 Oct 10;21:31-3
  • Salazar-Vizcaya L, Kouyos RD, Fehr J, Braun D, Estill J, Bernasconi E, Delaloye J, Stöckle M, Schmid P, Rougemont M, Wandeler G, Günthard HF, Keiser O, Rauch A; Swiss HIV Cohort Study. On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study. On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling study.
  • Nemeth J, Bernasconi E, Heininger U, Abbas M, Nadal D, Strahm C, Erb S, Zimmerli S, Furrer H, Delaloye J, Kuntzer T, Altpeter E, Sturzenegger M, Weber R, For The Swiss Society For Infectious Diseases And The Swiss Society For Neurology. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly. 2016 Dec 5;146:w14353.
  • Gruber JR, Sarro R, Delaloye J, Surmely JF, Siniscalchi G, Tozzi P, Jaques C, Jaton K, Delabays A, Greub G, Rutz T. Tropheryma whipplei bivalvular endocarditis and polyarthralgia: a case report. J Med Case Rep. 2015 18;9:259.
  • Cohen J, Vincent JL, Adhikari N, Machado F, Angus D, Calandra T, Jaton K, Giuleri S, Delaloye J, Opal S, Tracey K, van der Poll T and Pelfrene E. Sepsis - A Roadmap for Future Research. Lancet Infectious Disease 2015, Commission combined text v4 ;29-12-14.
  • Delaloye J, Filali-Mouhim A, Cameron MJ, Haddad EK, Harari A, Goulet JP, Gomez CE, Perdiguero B, Esteban M, Pantaleo G, Roger T, Sékaly RP, Calandra T. Interleukin 1- and type I interferon-dependent enhancement of the innate immune profile of a NYVAC-HIV-1 Env-Gag-Pol-Nef vaccine vector with dual deletion of type I and type II interferon-binding proteins. J Virol. 2015. pii: JVI.03061-14. Epub ahead of print
  • Perdiguero B, Gómez CE, Cepeda V, Sánchez-Sampedro L, García-Arriaza J, Mejías-Pérez E, Jiménez V, Sánchez C, Sorzano CÓ, Oliveros JC, Delaloye J, Roger T, Calandra T, Asbach B, Wagner R, Kibler KV, Jacobs BL, Pantaleo G, Esteban M. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles. J Virol. 2015; 89:970-88.
  • Delaloye J, Calandra T. Invasive candidiasis as a cause of sepsis in the critically ill patient. Virulence. 2014; 5:161-9.
  • Perdiguero B, Gómez CE, Di Pilato M, Sorzano CO, Delaloye J, Roger T, Calandra T, Pantaleo G, Esteban M. Deletion of the vaccinia virus gene A46R, encoding for an inhibitor of TLR signalling, is an effective approach to enhance the immunogenicity in mice of the HIV/AIDS vaccine candidate NYVAC-C. PLoS One. 2013; 8:e74831.
  • Delaloye J, Calandra T. Host innate immune responses to microbial pathogens. Curr Vasc Pharmacol. 2013; 11:123-32.
  • Roger T, Delaloye J, Chanson AL, Giddey M, Le Roy D, Calandra T. Macrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis. J Infect Dis. 2013 15:331-9.
  • Delaloye J, Greub G. Q fever, a zoonosis often overlooked. Rev Med Suisse. 2013; 9: 879-84.
  • Delaloye J, De Bruin I, Darling K, Knaup Reymond M, Sweep F, Roger T, Calandra T and Cavassini M. Increased macrophage migratory inhibitory factor (MIF) plasma levels in acute HIV-1 infection. Cytokine. 2012; 60:338-40.
  • Perdiguero B, Gómez CE, Nájera JL, Sorzano CO, Delaloye J, González-Sanz R, Jiménez V, Roger T, Calandra T, Pantaleo G, Esteban M. Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigens. PLoS One. 2012; 7:e48524.
  • Gómez CE, Perdiguero B, Jiménez V, Filali-Mouhim A, Ghneim K, Haddad EK, Quakkelaar ED, Delaloye J, Harari A, Roger T, Duhen T, Sékaly RP, Melief CJ, Calandra T, Sallusto F, Lanzavecchia A, Wagner R, Pantaleo G, Esteban M. Systems analysis of MVA-C induced immune response reveals its significance as a vaccine candidate against HIV/AIDS of clade C. PLoS One. 2012; 7:e35485.
  • Delaloye J, Baumgartner JD, Calandra T. Severe sepsis and septic shock. Rev Med Suisse 2006; 2; 806.898.
  • Delaloye J, Merlani G, Petignat C, Wenger A, Zaman K, Monnerat C, Matzinger O, Beck Popovic M, Vuichard P,  Ketterer N and Tarr PE. Nosocomial nontyphoidal salmonellosis after antineoplastic chemotherapy: reactivation of asymptomatic colonization? Eur J Clin Microbiol Infect Dis 2004; 23:751-75.


Book chapter

Delaloye J, Curdin C, Gilliet M, Pantaleo G and Ribi C. Infections associated with immunobiologics.  in Infectious Diseases. 4th Edition. Edited by Jonathan Cohen, 2015. Chapter 87.